4.6 Article

Development of a HiBiT-tagged reporter hepatitis E virus and its utility as an antiviral drug screening platform

Journal

JOURNAL OF VIROLOGY
Volume -, Issue -, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/jvi.00508-23

Keywords

hepatitis E virus; reporter virus; bioluminescent protein; HiBiT tag; ORF2 capsid protein; virus release; drug screening

Categories

Ask authors/readers for more resources

This study developed a reporter hepatitis E virus (HEV) and demonstrated its efficient replication, genetic stability, and infectivity. The researchers also simplified the measurement of luciferase activity and used it to evaluate the effects of introducing small interfering RNAs and inhibitors on HEV release. These findings contribute to the understanding of the HEV life cycle and provide a more convenient screening platform for candidate drugs targeting the late stage of HEV infection.
Previously, we developed an infectious hepatitis E virus (HEV) harboring the nanoKAZ gene in the hypervariable region of the open reading frame 1 (ORF1) of the HEV3b (JE03-1760F/P10) genome and demonstrated the usefulness for screening anti-HEV drugs that inhibit the early infection process. In the present study, we constructed another reporter HEV (HEV3b-HiBiT) by placing a minimized HiBiT tag derived from NanoLuc luciferase at the 3 & PRIME;-end of the viral capsid (ORF2) coding sequence. It replicated efficiently in PLC/PRF/5 cells, produced membrane-associated particles identical to those of the parental virus, and was genetically stable and infectious. The HiBiT tag was fused to both secreted ORF2s (ORF2s-HiBiT) and ORF2c capsid protein (ORF2c-HiBiT). The ORF2c-HiBiT formed membrane-associated HEV particles (eHEV3b-HiBiT). By treating these particles with digitonin, we demonstrated that the HiBiT tag was expressed on the surface of capsid and was present inside the lipid membrane. To simplify the measurement of luciferase activity and provide a more convenient screening platform, we constructed an ORF2s-defective mutant (HEV3b-HiBiT/& UDelta;ORF2s) in which the secreted ORF2s are suppressed. We used this system to evaluate the effects of introducing small interfering RNAs and treatment with an inhibitor or accelerator of exosomal release on HEV egress and demonstrated that the effects on virus release can readily be analyzed. Therefore, HEV3b-HiBiT and HEV3b-HiBiT/& UDelta;ORF2s reporters may be useful for investigating the virus life cycle and can serve as a more convenient screening platform to search for candidate drugs targeting the late stage of HEV infection such as particle formation and release.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available